Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi
After Sun Pharma appealed an injunction handed down in New Jersey federal court in November that blocked the U.S. launch of its alopecia med Leqselvi, the U.S. Court of Appeals for the Federal Circuit on Wednesday ruled in favor of the Indian drugmaker. Sun is no longer under any court order delaying or restricting Leqselvi’s market debut.
After Sun Pharma appealed an injunction handed down in New Jersey federal court in November that blocked the U.S. launch of its alopecia med Leqselvi, the U.S. Court of Appeals for the Federal Circuit on Wednesday ruled in favor of the Indian drugmaker. Sun is no longer under any court order delaying or restricting Leqselvi’s market debut.
